ArticleJournal of human hypertension2026
Serum levels of placenta growth factor, adiponectin and endothelin-1 correlate to the occurrence and outcomes of hypertensive disorders complicating pregnancy.
Article in Journal of human hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Serum placenta growth factor (PIGF), adiponectin, and endothelin-1 (ET-1) were associated with hypertension. However, it remains unclear whether these factors could predict the occurrence and prognosis of hypertensive disorders complicating pregnancy (HDCP). The enrolled pregnant women were classified into different groups according to diagnosis criteria. The demographic and clinical characteristics were compared among different groups. The levels of serum PIGF, adiponectin and ET-1 were determined. The predictive values of serum PIGF, adiponectin, and ET-1 for the occurrence and prognosis of HDCP were assessed using the receiver operating characteristic curve (ROC) analysis. There was a significant difference in systolic blood pressure, diastolic blood pressure, and proteinuria between the HDCP group and the normal pregnancy group. The level of serum PIGF and adiponectin decreased while ET-1 increased in the HDCP group compared to the normal pregnancy group. Furthermore, they had a similar change pattern with the progression of HDCP. The ROC analysis demonstrated that PIGF, adiponectin and ET-1 could effectively predict the occurrence and prognosis of HDCP. Compared to normal pregnant women, serum PIGF and adiponectin gradually decreased while ET-1 gradually increased with the progression of HDCP. Thus, they could effectively predict the occurrence and prognosis of HDCP.
Indexed as
Identifiers
41444387What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.